Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Overall survival · women with early breast cancer

Taxane‐containing chemotherapy leads to lower overall survival compared with any chemotherapy without taxane (high certainty).

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
HR 0.87 [0.83, 0.92]
27 studies · 39180 participants
High

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Disease‐free progression · women with early breast cancer

Taxane‐containing chemotherapy leads to lower disease‐free progression compared with any chemotherapy without taxane (high certainty).

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
HR 0.88 [0.85, 0.92]
29 studies · 41909 participants
High

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Quality of life · women with early breast cancer

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 7 participants
Low

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Febrile neutropenia · women with early breast cancer

Taxane‐containing chemotherapy showed no clear difference in febrile neutropenia compared with any chemotherapy without taxane (moderate certainty).

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
OR 1.43 [0.89, 2.31]
23 studies · 34154 participants
Moderate

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Neuropathy (including grade 3/4 sensory or motor neuropathy, or both) · women with early breast cancer

Taxane‐containing chemotherapy probably leads to higher neuropathy (including grade 3/4 sensory or motor neuropathy, or both) compared with any chemotherapy without taxane (moderate certainty).

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
OR 6.89 [3.23, 14.71]
22 studies · 31033 participants
Moderate

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Cardiotoxicity (including grade 3/4 and congestive cardiac failure) · women with early breast cancer

Taxane‐containing chemotherapy showed no clear difference in cardiotoxicity (including grade 3/4 and congestive cardiac failure) compared with any chemotherapy without taxane (moderate certainty).

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
OR 0.87 [0.56, 1.33]
23 studies · 32894 participants
Moderate

Occupational therapy vs usual care

BADL (primary outcome) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
1 participants
GRADE not reported

Occupational therapy vs usual care

5a. Visual attention overall (postintervention) · adults with cognitive impairment after stroke

2 findings from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 620 participants
Low
Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 293 participants
Low

Occupational therapy vs usual care

5c. Sustained visual attention (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 463 participants
Moderate

Occupational therapy vs usual care

Memory (specific cognitive function) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
6 participants
GRADE not reported

Occupational therapy vs usual care

Cognitive subdomain: working memory measured at the end of · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 420 participants
Low

Occupational therapy vs usual care

6b. Immediate verbal memory span (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 357 participants
Very low

Occupational therapy vs usual care

6c. Immediate spatial memory span (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 292 participants
Low

Occupational therapy vs usual care

Executive function (specific cognitive function) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
7 participants
GRADE not reported

Occupational therapy vs usual care

7a. Executive functional performance overall (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 550 participants
Very low

Occupational therapy vs usual care

7b. Cognitive flexibility (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 43 participants
Low

Occupational therapy vs usual care

1a. BADL (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 336 participants
Low

Occupational therapy vs usual care

1b. BADL (3‐month · adults with cognitive impairment after stroke

2 findings from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 73 participants
Low
Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 73 participants
Low

Occupational therapy vs usual care

2a. IADL (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 88 participants
Very low

Occupational therapy vs usual care

2b. Other ADL/IADL (postintervention) · adults with cognitive impairment after stroke

1 finding from 1 review

Occupational therapy for cognitive impairment in stroke patients 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 111 participants
Very low